NOXAFIL is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Posaconazole.
| Product ID | 0085-4331_125b529c-3a8d-4672-8264-da4834fabe79 |
| NDC | 0085-4331 |
| Product Type | Human Prescription Drug |
| Proprietary Name | NOXAFIL |
| Generic Name | Posaconazole |
| Dosage Form | Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-03-13 |
| Marketing Category | NDA / NDA |
| Application Number | NDA205596 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | POSACONAZOLE |
| Active Ingredient Strength | 18 mg/mL |
| Pharm Classes | Azole Antifungal [EPC],Azoles [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2014-03-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA205596 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-03-13 |
| Ingredient | Strength |
|---|---|
| POSACONAZOLE | 18 mg/mL |
| SPL SET ID: | b073b082-7b57-4423-8c06-4fd4263d6f84 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0085-1328 | NOXAFIL | posaconazole |
| 0085-2224 | NOXAFIL | posaconazole |
| 0085-4324 | NOXAFIL | posaconazole |
| 0085-4331 | NOXAFIL | posaconazole |
| 0254-2045 | POSACONAZOLE | posaconazole |
| 0406-7711 | POSACONAZOLE | posaconazole |
| 0527-2133 | POSACONAZOLE | Posaconazole |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NOXAFIL 77007334 3825429 Live/Registered |
MERCK SHARP & DOHME CORP. 2006-09-25 |
![]() NOXAFIL 75731165 2468349 Live/Registered |
MERCK SHARP & DOHME CORP. 1999-06-17 |
![]() NOXAFIL 75217327 not registered Dead/Abandoned |
SCHERING CORPORATION 1996-12-23 |